Medicinal application of epimedin C in treatment on diabetic liver injury
A technology for diabetes and liver damage, applied in the field of preparation of drugs for the treatment of diabetic liver damage, can solve the problem of not fully considering the taste and bioavailability of drugs, and it is difficult to reveal the material basis of epimedium in the treatment of diabetes and its complications To achieve the effect of improving the oxidative stress state of the liver, alleviating the disorder of lipid metabolism, and increasing the level of HDL-C
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0041] Example 1: Preparation of Chaohuoding C buccal tablets
[0042] A chaohuding C lozenge for the treatment of diabetic liver injury, and its prescription is made of the following mass percentage components: chaohuding C is 65%, arabinose is 9.8%, stevioside is 0.1%, microcrystalline fiber It is 15%, hypromellose is 9%, magnesium stearate is 1%, and absolute ethanol is 0.1%.
[0043] The preparation method of Chaohuoding C lozenge is:
[0044] Step 1, raw material weighing and pretreatment: according to the established mass percentage, respectively weigh Chaohuidine C, arabinose, stevioside, microcrystalline cellulose, hypromellose and magnesium stearate, and pass through a 60-mesh sieve.
[0045] Step 2. Preparation of soft material: take Chaohuidine C, add arabinose and steviol glycosides, use absolute ethanol as a wetting agent, stir well, add microcrystalline cellulose and hypromellose, stir evenly to make soft material.
[0046] Step 3. Granulation: Put the prepared soft mate...
Example Embodiment
[0048] Example 2
[0049] Example 2: Preparation of Chaohuoding C Coated Tablets
[0050] A Coated Tablet of Chaohuoding C for the treatment of diabetic liver injury, and its prescription is made of the following components by mass percentage: Chaohuding C is 49.8%, microcrystalline cellulose is 15%, and magnesium stearate is 1% , Hypromellose is 5%, steviol glycoside is 0.2%, glycerin is 1%, talc is 1%, and distilled water is 27%.
[0051] The preparation method of Chaohuoding C coated tablets is:
[0052] Step 1, raw material weighing and pretreatment: according to the established mass percentage, respectively weigh Chaohuidine C, microcrystalline cellulose, magnesium stearate and hypromellose, and pass through a 60 mesh sieve.
[0053] Step 2. Preparation of the tablet core: take Chaohuidine C, add microcrystalline cellulose and hypromellose, mix well, use distilled water as a binder to make a soft material, and then put the wet particles into 60℃ air-dried Dry in a box for about 1...
Example Embodiment
[0056] Example 3: Preparation of Chaohuoding C Hard Capsules
[0057] A Chaohuiding C capsule for treating diabetic liver injury is formulated with the following components in mass percentage: Chaohuiding C is 70%, and dietary fiber is 30%. In addition, several hard gelatin capsule shells for medicinal use are required.
[0058] The preparation method of Chaohuoding C hard capsule is:
[0059] Step 1, raw material weighing and pretreatment: Weigh Chaohuodin C and dietary fiber according to the established mass percentage, and pass through a 60-mesh sieve.
[0060] Step 2. Preparation of filling materials: Mix the chohuodin C and dietary fiber evenly.
[0061] Step 3, filling the capsule: the free inflow method is used to make the filling material enter the capsule shell, and then the capsule cap is fitted to obtain the Chaohuiding C hard capsule.
[0062] The following test examples further illustrate the therapeutic effect of Chaohuidine C on diabetic liver injury according to the pres...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap